Edelman MJ - Search Results

1

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.

Lara PN Jr, Redman MW, Kelly K, Edelman MJ, Williamson SK, Crowley JJ, Gandara DR; Southwest Oncology Group. Lara PN Jr, et al. Among authors: edelman mj. J Clin Oncol. 2008 Jan 20;26(3):463-7. doi: 10.1200/JCO.2007.13.0344. J Clin Oncol. 2008. PMID: 18202421 Clinical Trial.

2

Promising new agents in the treatment of non-small cell lung cancer.

Edelman MJ, Gandara DR. Edelman MJ, et al. Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402. Cancer Chemother Pharmacol. 1996. PMID: 8599859 Review.

3

Multimodality therapy in stage III non-small cell lung cancer.

Edelman MJ, Gandara DR, Roach M 3rd, Benfield JR. Edelman MJ, et al. Ann Thorac Surg. 1996 May;61(5):1564-72. doi: 10.1016/0003-4975(96)00044-6. Ann Thorac Surg. 1996. PMID: 8633990 Review.

4

Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.

Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD. Hesketh PJ, et al. Cancer J Sci Am. 1997 May-Jun;3(3):180-3. Cancer J Sci Am. 1997. PMID: 9161784 Clinical Trial.

5

Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.

Edelman MJ, Meyers FJ, Houston J, Lauder I. Edelman MJ, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-68-S15-71. Semin Oncol. 1997. PMID: 9346226 Clinical Trial.

6

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.

Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB. Gandara DR, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1997;41(1):75-8. doi: 10.1007/s002800050710. Cancer Chemother Pharmacol. 1997. PMID: 9443617 Clinical Trial.

7

Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration.

Gandara DR, Roila F, Warr D, Edelman MJ, Perez EA, Gralla RJ. Gandara DR, et al. Among authors: edelman mj. Support Care Cancer. 1998 May;6(3):237-43. doi: 10.1007/s005200050160. Support Care Cancer. 1998. PMID: 9629876 Review.

8

Small cell lung cancer: current status of new chemotherapeutic agents.

Edelman MJ, Gandara DR. Edelman MJ, et al. Crit Rev Oncol Hematol. 1998 Apr;27(3):211-20. doi: 10.1016/s1040-8428(98)00002-x. Crit Rev Oncol Hematol. 1998. PMID: 9649933 Review. No abstract available.

9

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy.

Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F. Edelman MJ, et al. Invest New Drugs. 1998;16(1):69-75. doi: 10.1023/a:1006026928733. Invest New Drugs. 1998. PMID: 9740546 Clinical Trial.

10

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters